MCP-1 as a potential target to inhibit the bone invasion by oral squamous cell carcinoma
Jingjing Quan1, Nigel A Morrison, Newell W Johnson
1Guanghua School of Stomatology, Hospital of Stomatology, Sun Yat-sen University & Guangdong Provincial Key Laboratory of Stomatology, Guangzhou, Guangdong 510055, China; School of Medical Science, Griffith University, QLD 4222, Australia.
Abstract:
Bone invasion is a common complication of oral squamous cell carcinoma (OSCC), and this study sought to explore whether suppressed expression of monocyte chemotactic protein-1 (MCP-1) can be used to inhibit the bone invasion by OSCC. Strong staining of MCP-1 protein was observed from 10 archival blocks of OSCC by immunohistochemistry (IHC). Real-time PCR showed MCP-1 mRNA was highly expressed by OSCC cell lines (SCC25, HN5, and Tca8113), and SCC25 cells had the highest expression. An expression construct of a dominant negative variant of MCP-1 with 7 amino acids truncated (7ND), in the vector pcDNA was used to transfect SCC25 cells, and resultant stabilized SCC25 cells (SCC25-7ND) were generated by antibiotic selection. 10% conditioned media (CM, supernatant) of SCC25-7ND cells efficiently inhibited the formation of human osteoclasts grown from CD14(+) monocyte subpopulation, comparing with 10% CM of SCC25 cells. Further, cells of SCC25 or SCC25-7ND were injected onto the surface of calvariae of nude mice to establish an animal model of bone invasion by OSCC. H&E staining showed well-differentiated OSCC was formed in both groups, tumour cells invading the bone while osteoclasts locating in typical resorption lacunae. TRAP staining indicated significantly fewer osteoclasts were found in calvariae with cells of SCC25-7ND in comparison to cells of SCC25. These data demonstrate the relevance of MCP-1 with research on bone invasion by OSCC, and suggest the potential value of MCP-1 as a target to inhibit this common complication.
Insights
Suppressing monocyte chemotactic protein-1 (MCP-1) expression inhibits oral squamous cell carcinoma (OSCC) bone invasion. This study shows MCP-1 inhibition reduces osteoclast formation, offering a potential therapeutic target for OSCC bone metastasis.
Area of Science:
- Oncology
- Immunology
- Biochemistry
Background:
- Bone invasion is a frequent complication of oral squamous cell carcinoma (OSCC).
- Monocyte chemotactic protein-1 (MCP-1) plays a role in inflammatory processes and cancer metastasis.
- Understanding MCP-1's role in OSCC bone invasion could reveal therapeutic targets.
Purpose of the Study:
- To investigate the role of MCP-1 in OSCC bone invasion.
- To explore the potential of suppressing MCP-1 to inhibit OSCC bone metastasis.
Main Methods:
- Immunohistochemistry (IHC) and real-time PCR were used to assess MCP-1 expression in OSCC tissues and cell lines.
- A dominant-negative MCP-1 variant (7ND) was used to transfect OSCC cells (SCC25).
- In vitro osteoclast differentiation and in vivo mouse calvariae models were employed to evaluate the effect of MCP-1 suppression on bone invasion.
Main Results:
- MCP-1 was highly expressed in OSCC tissues and cell lines, with SCC25 showing the highest expression.
- Transfected SCC25 cells (SCC25-7ND) with suppressed MCP-1 expression significantly inhibited osteoclast formation in vitro.
- In vivo studies demonstrated that SCC25-7ND cells caused significantly less osteoclast-mediated bone invasion compared to control SCC25 cells.
Conclusions:
- MCP-1 expression is closely linked to bone invasion in OSCC.
- Suppression of MCP-1 effectively inhibits osteoclast formation and subsequent bone invasion by OSCC.
- MCP-1 represents a promising therapeutic target for preventing or treating OSCC bone metastasis.
More Related Videos
12:03Multi-photon Imaging of Tumor Cell Invasion in an Orthotopic Mouse Model of Oral Squamous Cell Carcinoma
Published on: July 25, 2011
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
